Jörg B. Hans

Jörg B. Hans

Auto-generated profile, based on publicly available information

Jörg B. Hans

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in Eurosurveillance
Verified
Journal Article
Open access
SWSandra Witteveen
Sandra Witteveen
JHJörg B Hans
Jörg B Hans
RIRadosław Izdebski
Radosław Izdebski
HHHenrik Hasman
Henrik Hasman
ØSØrjan Samuelsen
Ørjan Samuelsen
AHAntoni P.A. P.A. Hendrickx
Antoni P.A. P.A. Hendrickx
Background: The war in Ukraine led to migration of Ukrainian people. Early 2022, several European national surveillance systems detected multidrug-resistant (MDR) bacteria related to Ukrainian patients. Aim: To investigate the genomic epidemiology of New Delhi metallo-β-lactamase (NDM)-producing Providencia stuartii from Ukrainian patients among European countries. Methods: Whole-genome sequencing of 66 isolates sampled in 2022–2023 in 10 European countries enabled whole-genome multilocus sequence typing (wgMLST), identification of resistance genes, replicons, and plasmid reconstructions. Five bla NDM-1-carrying-P. stuartii isolates underwent antimicrobial susceptibility testing (AST). Transferability to Escherichia coli of a bla NDM-1-carrying plasmid from a patient strain was assessed. Epidemiological characteristics of patients with NDM-producing P. stuartii were gathered by questionnaire. Results: wgMLST of the 66 isolates revealed two genetic clusters unrelated to Ukraine and three linked to Ukrainian patients. Of these three, two comprised bla NDM-1-carrying-P. stuartii and the third bla NDM-5-carrying-P. stuartii. The bla NDM-1 clusters (PstCluster-001, n = 22 isolates; PstCluster-002, n = 8 isolates) comprised strains from seven and four countries, respectively. The bla NDM-5 cluster (PstCluster-003) included 13 isolates from six countries. PstCluster-001 and PstCluster-002 isolates carried an MDR plasmid harbouring bla NDM-1, bla OXA-10, bla CMY-16, rmtC and armA, which was transferrable in vitro and, for some Ukrainian patients, shared by other Enterobacterales. AST revealed PstCluster-001 isolates to be extensively drug-resistant (XDR), but susceptible to cefiderocol and aztreonam–avibactam. Patients with data on age (n = 41) were 19–74 years old; of 49 with information on sex, 38 were male. Conclusion: XDR P. stuartii were introduced into European countries, requiring increased awareness and precautions when treating patients from conflict-affected areas.

1 June 2011 in Science of The Total Environment
Verified
Journal Article
Closed access
JHJ. Hans
J. Hans
CJC. Jöst
C. Jöst
GZG.-P. Zauke
G.-P. Zauke

8 January 2026 in Eurosurveillance
Verified
Journal Article
Open access
MSMirco Sandfort
Mirco Sandfort
JEJessica Eisfeld
Jessica Eisfeld
JHJörg B Hans
Jörg B Hans
FRFelix Reichert
Felix Reichert
DSDunja Said
Dunja Said
OGon behalf of the Generic IGS system development group
on behalf of the Generic IGS system development group
BACKGROUND: Carbapenemase-producing Enterobacterales (CPE) cause infections, particularly nosocomially, with limited treatment options. NDM-1-producing Klebsiella pneumoniae cases have substantially increased since 2022, associated with the Ukraine war. AIM: We aimed to investigate transmission patterns using Germany’s Integrated Genomic Surveillance (IGS), combining notifications and sequence data. METHODS: We selected NDM-1-producing K. pneumoniae cases, confirmed by isolates between 1 January 2022 and 28 February 2023. Isolates were Illumina whole genome-sequenced and linked to notifications. Clusters were defined as ≤ 12 allelic differences in core genome-wide single nucleotide variant-based genotyping. Cluster categories were: ‘no exposure abroad’, ‘exposure in Ukraine’ or ‘other exposure abroad’ if ≥ one case stayed in Ukraine or elsewhere. Follow-up of 13 clusters examined further exposure information. RESULTS: Among 424 cases of most frequent sequence types, 326 (77%) belonged to 61 clusters. Seventeen (28%) clusters were associated with no exposure abroad, 33 (54%) with exposure in Ukraine, seven (11%) with other exposure abroad, and four (7%) had insufficient data. Cases in clusters with exposure in Ukraine were more dispersed, younger, and more often wound-infected than in other exposure location categories (p < 0.01). Cluster follow-up revealed one cluster with all cases from Ukraine or Russia, another with nosocomial transmission following case importation, and a third with all cases from one German hospital without exposure abroad. CONCLUSION: Most cases were in clusters, suggesting preventable chains of transmission. Three patterns emerged: transmission abroad, transmission in German hospitals from imported cases or local outbreaks. IGS can identify where transmission could be interrupted. International cooperation needs strengthening to prevent CPE spread.

24 September 2026 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
FRFelix Reichert
Felix Reichert
MPMark Perry
Mark Perry
MSMirco Sandfort
Mirco Sandfort
SHSebastian Haller
Sebastian Haller
DSDunja Said
Dunja Said
JHJörg B. Hans
Jörg B. Hans
Background: Epidemiologic surveillance is one pillar in the global efforts to stop the spread of antibiotic-resistant bacteria (ARB) and increasingly includes whole genome sequencing (WGS). However, no review systematically examined the characteristics of such surveillance systems until February 2025. We conducted a systematic review to identify and describe routine surveillance systems of ARB, that integrate WGS and epidemiological information. Methods: A protocol was developed and published on PROSPERO. We searched 8 databases and Google. Included articles needed to report on a national or subnational surveillance system and include epidemiological data as well as WGS of carbapenem-resistant or carbapenemase-producing Enterobacterales (CRE) or Acinetobacter spp., methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococci (VRE). Surveillance system characteristics were analysed narratively. Results: From 13,142 searched articles, 41 were included. The publications were stratified by pathogen. The strata demonstrated similar WGS approaches with a predominance of short-read sequencing platforms. Typing methods mostly included multilocus sequence typing and single nucleotide polymorphism -based analyses for higher discrimination. Reported cluster thresholds showed a wide range of values within and between species. Across strata, there was often a low level of epidemiological data collection, such as exposure of cases, and integration in cluster analyses. WGS surveillance complemented with at least basic epidemiological data has been reported from all six WHO regions for CRE. However, fewer studies and no studies at all for MRSA and VRE were included from the African, Eastern Mediterranean and South-East Asian regions. The national coverage of surveillance ranged from 36% for MRSA to 56% for CRE. Conclusion: WGS-based surveillance on ARB is employed worldwide with predominant use of short-read technology and largely consistent typing methods. Substantial variation in genomic clustering thresholds underscores the need for internationally harmonized standards for data analysis. Insufficient epidemiological information or lacking integration in the analysis of WGS data may reduce the ability to infer transmission pathways and identify outbreaks. To fully exploit the potential of WGS-based surveillance systems in this context for public health and contain current and prevent future outbreaks, we thus call for a routine collection of detailed epidemiological data.